Jiangsu gdk Biotechnology Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Jiangsu gdk Biotechnology Co., Ltd.

Why is Jiangsu gdk Biotechnology Co., Ltd. ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Net Sales has grown by an annual rate of -26.70% and Operating profit at -229.21% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times

The company has declared negative results in Jan 70 after 3 consecutive negative quarters

OPERATING CASH FLOW(Y) Lowest at CNY -126.8 MM
ROCE(HY) Lowest at -14.59%
DEBT-EQUITY RATIO (HY) Highest at 0 %

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 49.55%, its profits have risen by 36.7%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Jiangsu gdk Biotechnology Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Jiangsu gdk Biotechnology Co., Ltd.

2.17%

0.47

69.50%

China Shanghai Composite

19.22%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-26.34%

EBIT Growth (5y)

-230.55%

EBIT to Interest (avg)

-28.86

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.15

Sales to Capital Employed (avg)

0.06

Tax Ratio

20.07%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

3.81%

ROE (avg)

2.79%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.60

EV to EBIT

-2.98

EV to EBITDA

-3.37

EV to Capital Employed

0.59

EV to Sales

5.46

PEG Ratio

Dividend Yield

ROCE (Latest)

-19.68%

ROE (Latest)

-17.01%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

NET PROFIT(HY)

Higher at CNY -114.07 MM

RAW MATERIAL COST(Y)

Fallen by -37.46% (YoY

NET SALES(9M)

Higher at CNY 110.26 MM

-25What is not working for the Company

INTEREST(HY)

At CNY 0.94 MM has Grown at 41.48%

OPERATING CASH FLOW(Y)

Lowest at CNY -147.76 MM

NET SALES(HY)

At CNY 39.12 MM has Grown at -13.76%

ROCE(HY)

Lowest at -15.26%

DEBT-EQUITY RATIO (HY)

Highest at -4.52 %

NET PROFIT(Q)

Fallen at -29.37%

Here's what is working for Jiangsu gdk Biotechnology Co., Ltd.

Raw Material Cost

Fallen by -37.46% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Jiangsu gdk Biotechnology Co., Ltd.

Interest

At CNY 0.94 MM has Grown at 41.48%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow

Lowest at CNY -147.76 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

At CNY 39.12 MM has Grown at -13.76%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Net Profit

Fallen at -29.37%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Debt-Equity Ratio

Highest at -4.52 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio